In a bold signal of growing institutional interest in digital assets, two Nasdaq-listed firms—10X Capital and Liminatus Pharma—have unveiled billion-dollar strategies centered around Binance Coin (BNB), positioning the token as a cornerstone for corporate treasury diversification.
10X Capital Launches First BNB-Exclusive Treasury Vehicle
10X Capital, in partnership with CEA Industries, has closed a $500 million private placement to establish the world’s largest publicly listed BNB-only treasury company. With additional warrant exercises, the deal could swell to $1.25 billion. The new entity will accumulate and manage BNB through long-term strategies like staking and lending within the Binance ecosystem.
Backed by over 140 institutional investors, including Pantera Capital and Blockchain.com, the venture will be led by Galaxy Digital co-founder David Namdar. He framed the initiative as a transparent, U.S.-regulated bridge for traditional investors to access the BNB ecosystem.
Liminatus Pharma Bets $500M on BNB Through Subsidiary
Biotech firm Liminatus Pharma has also joined the BNB treasury wave, announcing plans to raise $500 million through its new subsidiary, American BNB Strategy. The firm cited BNB’s robust technical infrastructure, staking model, and global adoption as key drivers behind the move. The capital will be safeguarded using Ceffu’s custody infrastructure and will focus on long-term growth, not short-term trading.
Liminatus emphasized that its biotech mission remains unchanged, and the BNB strategy is designed to complement shareholder value, not distract from core operations.
Why It Matters
These moves reflect a shift in corporate thinking around crypto assets. Instead of speculative trading, public companies are increasingly treating digital tokens like BNB as strategic reserve assets, much like cash or gold.
Chart of the Day
